106 related articles for article (PubMed ID: 2119202)
1. Synergistic effects of TGIF and interferon gamma (IFN-gamma) on tumor cell growth. TGIF and IFN-gamma.
Katano M; Yamamoto H; Nakamura M; Matsuo T; Hisatsugu T
Biotherapy; 1990; 2(1):33-40. PubMed ID: 2119202
[TBL] [Abstract][Full Text] [Related]
2. Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation.
Katano M; Yamamoto H; Mizoguchi T; Hisatsugu T
Cancer Immunol Immunother; 1988; 27(3):198-204. PubMed ID: 3141056
[TBL] [Abstract][Full Text] [Related]
3. Activation of human peripheral blood-derived monocytes by OK-432 (Streptococcus pyogenes): augmented cytotoxicity and secretion of TNF and synergy with rIFN-gamma.
Bonavida B; Jewett A
Cell Immunol; 1989 Oct; 123(2):373-83. PubMed ID: 2507170
[TBL] [Abstract][Full Text] [Related]
4. A possible clinical application of multicytokine-producing cytotoxic mononuclear cell (MCCM) therapy.
Katano M; Kubota E; Yamamoto H; Nakamura M; Matsuo T; Hisatsugu T; Katsuki T; Koga H; Ikezaki K; Tabuchi K
Biotherapy; 1991; 3(4):373-9. PubMed ID: 1786201
[TBL] [Abstract][Full Text] [Related]
5. Effect of soluble factors derived from oral cancer cells on the production of interferon-γ from peripheral blood mononuclear cells following stimulation with OK-432.
Ohe G; Sasai A; Uchida D; Tamatani T; Nagai H; Miyamoto Y
Oncol Rep; 2013 Aug; 30(2):945-51. PubMed ID: 23685791
[TBL] [Abstract][Full Text] [Related]
6. The antitumor effects of locally injecting human peripheral blood mononuclear cells treated with OK-432 into the tumor site: the possible role of a tumor growth inhibitory factor (TGIF).
Katano M; Mizoguchi T; Yamamoto H; Nakamura M; Matsuo T; Hisatugu T; Kisu T; Yamaoka K; Tokunaga O
Jpn J Surg; 1990 Jan; 20(1):76-82. PubMed ID: 2304290
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effects of interferon gamma in combination with alpha-difluoromethylornithine on human carcinoma cell cultures.
Klouche M; Kirchner H; Hölzel F
J Cancer Res Clin Oncol; 1994; 120(12):700-6. PubMed ID: 7798293
[TBL] [Abstract][Full Text] [Related]
8. Tumoricidal effect of human PBMC following stimulation with OK-432 and its application for locoregional immunotherapy in head and neck cancer patients.
Kubota E; Katano M; Kurokawa H; Imamura H; Katsuki T; Yamamoto H; Hisatsugu T; Nagumo F; Tadano J
J Craniomaxillofac Surg; 1993 Jan; 21(1):30-7. PubMed ID: 8445052
[TBL] [Abstract][Full Text] [Related]
9. A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells.
Morisaki T; Matsunaga H; Beppu K; Ihara E; Hirano K; Kanaide H; Mori M; Katano M
Anticancer Res; 2000; 20(5B):3363-73. PubMed ID: 11131636
[TBL] [Abstract][Full Text] [Related]
10. [OK 432-induced production of IFN-gamma in peripheral mononuclear cells from healthy subjects and patients with cancer].
Matsumoto H; Izutani R; Terada M; Noguchi J; Shiraha S; Kuyama T; Aoki N
Nihon Gan Chiryo Gakkai Shi; 1989 Apr; 24(4):751-8. PubMed ID: 2506311
[TBL] [Abstract][Full Text] [Related]
11. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
Satoh M; Inagawa H; Shimada Y; Soma G; Oshima H; Mizuno D
J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
[TBL] [Abstract][Full Text] [Related]
12. Generation of activated killer-like cells by OK-432-mediated production of interleukin 1, interleukin 2, and interferon-gamma in vitro.
Ujiie T
Jpn J Exp Med; 1987 Dec; 57(6):333-8. PubMed ID: 3131563
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cytokine effects on mouse pancreatic alpha-cell and beta-cell lines. Viability, secretory function, and MHC antigen expression.
Hamaguchi K; Leiter EH
Diabetes; 1990 Apr; 39(4):415-25. PubMed ID: 2108069
[TBL] [Abstract][Full Text] [Related]
15. [Enhancing effects on interferon-gamma production by combination of OK-432 and interferon-alpha in patients with head and neck cancer].
Sugiyama M; Morisaki N; Konishi K; Go K; Sugita M; Nakai Y
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2200-6. PubMed ID: 6435540
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
Saito M; Yamaguchi T; Aonuma E; Noda T; Edina T; Ishida N
Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888
[TBL] [Abstract][Full Text] [Related]
17. OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity.
Pan K; Lv L; Zheng HX; Zhao JJ; Pan QZ; Li JJ; Weng DS; Wang DD; Jiang SS; Chang AE; Li Q; Xia JC
Immunol Cell Biol; 2014 Mar; 92(3):263-74. PubMed ID: 24296809
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH
Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482
[TBL] [Abstract][Full Text] [Related]
19. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy for renal cell carcinoma using IFN-gamma and OK-432: in vitro study.
Muraki J
Keio J Med; 1990 Mar; 39(1):21-5. PubMed ID: 2113148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
